Skip to main content
Grouped view 1739 records · Page 14/35

Prohibited Cosmetic Substances — Annex II

Annex II lists substances prohibited as intentionally added cosmetic ingredients. Article 17 separately addresses technically unavoidable unintended small quantities under good manufacturing practice and the Article 3 safety requirement. This page contains 1739 records.

How this annex works

Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.

  • 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
  • Prohibition covers intentional addition; there is no permitted concentration.
  • Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
  • Absence from Annex II is not permission — most substances appear in no annex at all.

Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.

The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.

Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.

The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.

Checked against

Annex II records

1739 total
Records in this list, 1739 in total
EntrySubstanceCASMax concentrationFlags
1596Cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-olCAS 94361-06-5 94361-06-5 CMR
1597Silver zinc zeoliteCAS 130328-20-0 130328-20-0 CMR
1598Cadmium carbonateCAS 513-78-0 513-78-0 CMR
1599Cadmium hydroxide; cadmium dihydroxideCAS 21041-95-2 21041-95-2 CMR
16Alkyne alcohols, their esters, ethers and salts
1605,5-Diphenyl-4-imidazolidone (Doxenitoin (INN))CAS 3254-93-1 3254-93-1
1600Cadmium nitrate; cadmium dinitrateCAS 10325-94-7 10325-94-7 CMR
1601Dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)] stannaneCAS 77-58-7 77-58-7 CMR
1602Clorofene; chlorophene; 2-benzyl-4-chlorophenolCAS 120-32-1 120-32-1 CMR
1603Anthraquinone; 9,10-anthraquinoneCAS 84-65-1 84-65-1 CMR
1604Nonadecafluorodecanoic acid [1]; Ammonium nonadecafluorodecanoate [2]; Sodium nonadecafluorodecanoate [3]CAS 335-76-2 [1] 3108-42-7 [2] 3830-45-3 [3] 335-76-2 [1] 3108-42-7 [2] 3830-45-3 [3] CMR
1605N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/wCAS 5625-90-1 5625-90-1 CMR
1606Reaction products of paraformaldehyde with 2-hydroxypropylamine (3:2); [formaldehyde released from 3,3'-methylenebis[5–methyloxazolidine]; [formaldehyde released from oxazolidin]; [MBO] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w
1607Reaction products of paraformaldehyde with 2-hydroxypropylamine (1:1)); [formaldehyde released from a,a,a-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w
1608MethylhydrazineCAS 60-34-4 60-34-4 CMR
1609Triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; a-tert-butyl-ß-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanolCAS 55219-65-3 55219-65-3 CMR
161Probenecid (INN)CAS 57-66-9 57-66-9
1610Thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridyl-methyl)-1-3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamideCAS 111988-49-9 111988-49-9 CMR
1611Carbetamide (ISO); (R)-1-(ethylcarbamoyl) ethyl-carbanilate; (2R)-1-(ethylamino) -1-oxopro-pan-2-yl-phenylcarbamateCAS 16118-49-3 16118-49-3 CMR
1612Phosmet (ISO); S-[(1,3-dioxo-1,3-dihydro-2H- isoindol-2-yl)methyl]-O,O-dimethyl phosphorodithioate; O,O-dimethyl-S-phthalimidomethyl phosphorodithioateCAS 732-11-6 732-11-6 CMR
1613Potassium permanganateCAS 7722-64-7 7722-64-7 CMR
16142-Benzyl-2-dimethylamino-4'- morpholinobutyrophenoneCAS 119313-12-1 119313-12-1 CMR
1615Quizalofop-p-tefuryl (ISO); (+/–) tetrahydrofurfuryl (R)-2-[4-(6- chloroquinoxalin-2-yloxy)phenyloxy]propionateCAS 200509-41-7 200509-41-7 CMR
1616Propiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4- dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl}-1H- 1,2,4-triazoleCAS 60207-90-1 60207-90-1 CMR
1617Pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoateCAS 243973-20-8 243973-20-8 CMR
1618Tetramethrin; (1-Cyclohexene-1,2-Dicarboximido)Methyl Chrysanthemate; 2,2-Dimethyl-3-(2-Methyl-1-Propenyl)Cyclopropanecarboxylic Acid (1,3,4,5,6,7-Hexahydro-1,3-Dioxo-2H-Isoindol-2-yl)Methyl EsterCAS 7696-12-0 7696-12-0 CMR
1619(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2- methylprop-1-enyl)cyclopropanecarboxylateCAS 1166-46-7 1166-46-7 CMR
162Disulfiram (INN); thiram (ISO) (INN)CAS 97-77-8 / 137-26-8 97-77-8 / 137-26-8
1620Spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo- 1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrateCAS 148477-71-8 148477-71-8 CMR
1621Reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy) but-2-ylamineCAS 897393-42-9 897393-42-9 CMR
16221-VinylimidazoleCAS 1072-63-5 1072-63-5 CMR
1623Amisulbrom (ISO)3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamideCAS 348635-87-0 348635-87-0 CMR
1624Pirimicarb (ISO); 2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamateCAS 23103-98-2 23103-98-2 CMR
16251,2-Dichloropropane; propylene dichlorideCAS 78-87-5 78-87-5 CMR
1626Phenol, dodecyl-, branched [1]; Phenol, 2-dodecyl-, branched [2]; Phenol, 3-dodecyl-, branched [3]; Phenol, 4-dodecyl-, branched [4]; Phenol, (tetrapropenyl) derivatives [5]CAS 121158-58-5 [1]; 1801269-80-6 [2] ; 1801269-77-1 [3]; 210555-94-5 [4]; 74499-35-7 [5] 121158-58-5 [1]; 1801269-80-6 [2] ; 1801269-77-1 [3]; 210555-94-5 [4]; 74499-35-7 [5]
1627Coumatetralyl (ISO); 4- hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl) coumarinCAS 5836-29-3 5836-29-3 CMR
1628Difenacoum (ISO); 3-(3- biphenyl-4-yl-1,2,3,4- tetrahydro-1-naphthyl)- 4-hydroxycoumarinCAS 56073-07-5 56073-07-5 CMR
1629Brodifacoum (ISO); 4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarinCAS 56073-10-0 56073-10-0 CMR
163Emetine, its salts and derivativesCAS 483-18-1 483-18-1
1630Flocoumafen (ISO); reaction mass of: cis-4- hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarinCAS 90035-08-8 90035-08-8 CMR
1631Acetochlor (ISO); 2- chloro-N-(ethoxymethyl)-N-(2-ethyl-6- methylphenyl)acetamideCAS 34256-82-1 34256-82-1 CMR
1632e-Glass microfibres of representative compositionCMR
1633Glass microfibres of representative compositionCMR
1634Bromadiolone (ISO); 3- [3-(4′-bromobiphenyl- 4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy- 2H-chromen-2-oneCAS 28772-56-7 28772-56-7 CMR
1635Difethialone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]- 4-hydroxy-2H-1-benzothiopyran-2-oneCAS 104653-34-1 104653-34-1 CMR
1636Perfluorononan-1-oic acid [1] and its sodium [2] and ammonium [3] saltsCAS 375-95-1 [1] / 21049-39-8 [2] / 4149-60-4 [3] 375-95-1 [1] / 21049-39-8 [2] / 4149-60-4 [3] CMR
1637Dicyclohexyl phthalateCAS 84-61-7 84-61-7 CMR
16383,7-Dimethylocta-2,6- dienenitrileCAS 5146-66-7 5146-66-7 CMR
1639Bupirimate (ISO); 5-butyl-2-ethylamino-6- methylpyrimidin-4-yl dimethylsulfamateCAS 41483-43-6 41483-43-6 CMR
164Ephedrine and its saltsCAS 299-42-3 299-42-3

How to use this grouped view

Annex II contains substances prohibited in cosmetic products. Use this grouped view when you want to scan 1739 prohibited-substance records quickly by name, identifier and linked entry page.

Open an individual record when you need the full legal wording, concentration logic, warnings or cross-links to related identifiers.